HRTX

Heron Therapeutics (HRTX)

About Heron Therapeutics (HRTX)

Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in Cary, NC.

Details

Daily high

$1.25

Daily low

$1.20

Price at open

$1.25

52 Week High

$2.30

52 Week Low

$0.74

Market cap

228.3M

Dividend yield

0.00%

Volume

1.8M

Avg. volume

2.3M

P/E ratio

-10.04

Heron Therapeutics News

Details

Daily high

$1.25

Daily low

$1.20

Price at open

$1.25

52 Week High

$2.30

52 Week Low

$0.74

Market cap

228.3M

Dividend yield

0.00%

Volume

1.8M

Avg. volume

2.3M

P/E ratio

-10.04